Defining "True and Non-Misleading" for Pharmaceutical Promotion

J Law Med Ethics. 2018 Jun;46(2):552-554. doi: 10.1177/1073110518782970.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Industry / legislation & jurisprudence*
  • Evidence-Based Medicine
  • Humans
  • Marketing / legislation & jurisprudence*
  • Off-Label Use / legislation & jurisprudence*
  • United States
  • United States Food and Drug Administration